Publication Date: February 23, 2026 Published By: USA Today Article Link: https://www.usatoday.com/story/special/contributor-content/2026/02/23/top-entrepreneurs-going-into-2026/88825698007/ Entrepreneurship heading into 2026 looks very different from what it did even a few years ago. A look back just a half a decade reveals a growth-at-all-costs movement, which resulted in a lot of boom-or-bust businesses that didn’t last. That trend has cooled […]
Summary NeOnc Technologies Holdings is a micro-cap biotech focused on innovative brain cancer treatments, NEO100 and NEO212, both in early clinical trials. NTHI’s financials are challenging, with no revenue, rising R&D expenses, and a significant cash burn, but a $50M Quazar partnership is set to transform its outlook. The Quazar deal will provide crucial funding, […]
Publication Date: March 13, 2025Published By: Venture BeatArticle Link: https://venturebeat.com/business/building-biotech-excellence-the-growth-strategy-behind-neonc-technologies-vision/ In his years as Director of Surgical Neuro-Oncology at the University of Southern California (USC), Dr. Thomas Chen has witnessed countless innovations in the world of cancer treatment. However, before helping create NeOnc’s potential treatments for biotech company NeOnc, Dr. Chen reflected on the many challenges […]
Publication Date: March 27, 2025Published By: Healthcare ExecutiveArticle Link: https://www.healthcareexecutive.in/blog/usc-licensed-startup On Wednesday, a USC-licensed startup biomedical company and Keck Medicine of USC neurosurgeon focused on treating brain cancer are taking their invention public along with India’s partnership for clinical trials. A USC-licensed startup that developed an intranasal drug delivery system for brain tumors marked a […]
Publication Date: March 25, 2025 Published By: USC Today Article Link: https://today.usc.edu/nasdaqs-opening-bell-will-ring-for-usc-research-startup/ A USC-licensed startup biomedical company and a Keck Medicine of USC neurosurgeon focused on treating brain cancer are taking their invention public. Such collaborations are an important way for researchers to bring promising treatments to patients. NeOnc founder Thomas Chen of Keck […]
Publication Date: March 25, 2025 Published By: USC Today Article Link: https://healthcare360magazine.com/nasdaq-visionaries-neonc-technologies/ The landscape of healthcare is in a state of perpetual evolution, driven by relentless innovation and a desire to improve patient outcomes. As we move through 2025, the NASDAQ platform serves as a vital barometer for these advancements, showcasing the “Trailblazers in Healthcare […]
Publication Date: March 14, 2025 Published By: Wall Street Journal Article Link: https://www.wsj.com/articles/healthcare-entrepreneurs-express-hope-concern-over-rfk-jr-confirmation-a0548927 FDA Head Robert F. Kennedy Jr. While several entrepreneurs expressed optimism, some said they were concerned vaccines could become more difficult to develop under his tenure. Kennedy has previously linked vaccines to autism and called for more testing and making vaccine-safety data […]
Publication Date: February 19, 2025 Published By: New York Business Journal Article Link: https://www.bizjournals.com/newyork/news/2025/02/19/expanding-horizons-neonc-technologies-bold-vision.html NeOnc Executive Team: (l-r) Patrick Walters, Dr. Thomas Chen, Amir F. Heshmatpour, Keithly A. Garnett The biotechnology industry is influencing advancements in medicine, agriculture, environmental science, and industrial processes. With its potential to transform human health and address critical global challenges, […]
In a gripping new episode of New Frontiers by Planet TV Studios, viewers are taken inside the revolutionary world of NeOnc Technologies Holdings, Inc., a biotech company redefining the battle against aggressive brain cancers. At the heart of this transformation is Dr. Thomas Chen, Director of Surgical Neuro-Oncology at USC and NeOnc’s founder. The episode […]
Publication Date: February 5, 2025 Published By: The Bio Report Podcast Article Link: https://open.spotify.com/episode/0raRIZm6OicjYXtrZSLdq9 NeOnc’s CEO and CSO Dr. Thomas Chen sat down for an interview on the Bio Report Podcast. The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy. “One of the […]
